Antipsychotics for maintenance therapy of scizophrenia

Posted byJoseph Thornton MDPosted inBlog
16bf102fc319d621a456d9f821071253_normal.jpeg spacer.png
The Lancet
⁦‪@TheLancet‬⁩
logo_twitter-1497383721365.png
spacer_464x1-1582829598167.png
This study suggests choice of antipsychotic for maintenance treatment of adults with schizophrenia should be guided mainly by tolerability; authors report no clear differences between antipsychotics for relapse prevention. hubs.li/Q0156dN20 pic.twitter.com/2MGZz34Ven
3/1/22, 12:04 PM

Joseph (Joe) E. Thornton, M.D., DFAPA

Published by Joseph Thornton MD

Teacher, Clinical Supervisor, [AIdvisor] Retired Clinical Associate Professor, Psychiatry, University of Florida Affiliation is for identification only. All content and opinions are my own.

Leave a comment